Gene · 5172
Papers3,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Properties of Patient-Reported Outcome Measures for Post-Traumatic Stress Disorder in North Korean Defectors: A Scoping Review. | Psychiatry Investig | 2023 | 37525615 | PubTator, text mining | PubMed |
| Comparative Analysis of Carotenoid Profiles and Biosynthetic Gene Expressions among Ten Plum Cultivars. | Plants (Basel) | 2023 | 37514325 | PubTator, text mining | PubMed |
| CaCu3Ti4O12 Perovskite Materials for Advanced Oxidation Processes for Water Treatment. | Nanomaterials (Basel) | 2023 | 37513130 | PubTator, text mining | PubMed |
| A Case of Class I 17p13.3 Microduplication Syndrome with Unilateral Hearing Loss. | Genes (Basel) | 2023 | 37510238 | PubTator, text mining | PubMed |
| The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond. | Cancers (Basel) | 2023 | 37509263 | PubTator, text mining | PubMed |
| Multimorbidity due to novel pathogenic variants in the WFS1/RP1/NOD2 genes: autosomal dominant congenital lamellar cataract, retinitis pigmentosa and Crohn's disease in a British family. | BMJ Open Ophthalmol | 2023 | 37493686 | PubTator, text mining | PubMed |
| The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease. | Antibodies (Basel) | 2023 | 37489370 | PubTator, text mining | PubMed |
| Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy. | J Nanobiotechnology | 2023 | 37482608 | PubTator, text mining | PubMed |
| FDG uptake reflects an immune-enriched subtype of thyroid cancer: Clinical implications of imaging-based molecular characterization. | Cancer Med | 2023 | 37466323 | PubTator, text mining | PubMed |
| Hypertensive disorders of pregnancy and risk of asthma and chronic obstructive pulmonary disease: a prospective cohort study. | Lancet Reg Health Am | 2023 | 37457814 | PubTator, text mining | PubMed |
| The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer. | Front Immunol | 2023 | 37457685 | PubTator, text mining | PubMed |
| Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases. | Front Endocrinol (Lausanne) | 2023 | 37455925 | PubTator, text mining | PubMed |
| Causes of hearing loss and implantation age in a cohort of Danish pediatric cochlear implant recipients. | Int J Pediatr Otorhinolaryngol | 2023 | 37441990 | PubTator, text mining | PubMed |
| Variability in Cochlear Implantation Outcomes in a Large German Cohort With a Genetic Etiology of Hearing Loss. | Ear Hear | 2023 | 37438890 | PubTator, text mining | PubMed |
| LPS binding protein and activation signatures are upregulated during asthma exacerbations in children. | Respir Res | 2023 | 37438758 | PubTator, text mining | PubMed |
| A new and novel high-fidelity genome editing tool for banana using Cas-CLOVER. | Plant Biotechnol J | 2023 | 37402217 | PubTator, text mining | PubMed |
| In vivo dynamics and regulation of DNA G-quadruplex structures in mammals. | Cell Biosci | 2023 | 37381029 | PubTator, text mining | PubMed |
| The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold? | Expert Opin Pharmacother | 2023 | 37379072 | PubTator, text mining | PubMed |
| Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review. | Biomedicines | 2023 | 37371790 | PubTator, text mining | PubMed |
| [Results of combined newborn hearing and deafness gene screening in Yuncheng area of Shanxi Province]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37368382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5172/papers?page=19